Table 3.
Number and percentage of patients with metabolic abnormalities by type of diabetes.
| T1DM | LADA | T2DM | |
|---|---|---|---|
| n | 316 | 587 | 14,589 |
| Waist circumference ≥90 cm in male and 85 cm in female, n (%)* | 71 (22.5) | 186 (31.7) | 7,332 (50.3) |
| Systolic/Diastolic BP ≥130/85 mmHg, n (%)* | 111 (35.1) | 281 (47.9) | 8,741 (59.9) |
| TGs ≥1.7 mmol/L, n (%)* | 88 (27.8) | 199 (33.9) | 7,516 (51.5) |
| HDL-C <1.04 mmol/L, n (%)* | 106 (33.5) | 172 (29.3) | 5,569 (38.2) |
| Metabolic syndrome, n (%)* | 108 (34.2) | 260 (44.3) | 9,936 (68.1) |
| HOMA2-IR | 0.25 (0.09–0.52) | 1.01 (0.53–1.67) | 1.53 (1.00–2.20) |
T1DM, type 1 diabetes mellitus; LADA, latent autoimmune diabetes in adults; T2DM, type 2 diabetes mellitus; BP, blood pressure.
*
Data of patients with parameters above the cut-point defined by CDS metabolic syndrome criteria were expressed as number (%); HOMA2-IR were expressed as median (interquartile range).